Additional information
Author Affiliations and Disclosures: David Skaggs, Children’s Hospital Los Angeles, GSF, GSSG, SRS, Journal of Childrens Orthopaedics, Spine Deformity, Orthobullets, Grand Rounds, Medtronic, Zipline Medical, Inc., Zimmer Biomet, Greensunmedical, Orthopaedic Research and Education Foundation: Scientific Forum Grant/Spine Care, POSNA, Ellipse, Wolters Kluwer Health-Lippincott Williams and Wilkins, Johnson and Johnson; Growing Spine Study Group, Growing Spine Foundation, Nuvasive, POSNA; Michael Vitale, Columbia University Medical Center, Children’s Spine Foundation, IPOS, POSNA, SSG, Biomet, Medtronic Sofamor Danek, Stryker, Wellinks, CSSG, SRS, OREF, OSRF, DePuy, DePuy, A Johnson & Johnson Company, FOX, Children’s Spine Foundation, Medtronic, OMEGA, Synthes, Morgan Stanley Children’s Hospital of New York, SSG; John Smith, University of Utah, Chest Wall and Spine Deformity Research Foundation, Children’s Spine Foundation, Biomet, DePuy Synthes, Spine, Ellipse Technologies, Globus Medical, Spinegaurd, Synthes, VEPTR 2; Purnendu Gupta, Shriners Hospitals for Children-Chicago, Depuy Johnson and Johnson; Alexander Nazareth, Children’s Hospital Los Angeles; Lindsay Andras, Children’s Hospital Los Angeles, POSNA, SRS, Eli Lilly, Orthobullets, Biomet, Medtronic; Growing Spine Study Group, Growing Spine Foundation, Nuvasive, POSNA; Ali Siddiqui, Children’s Spine Study Group, Ken Illingworth, Children’s Hospital Los Angeles
Rights and permissions
About this article
Cite this article
Siddiqui, A., Nazareth, A., Andras, L. et al. 18% of EOS patients Treated with MCGR have Minimal Lengthening Episodes Resulting in < 1 mm of Distraction. Spine Deform 6, 806–807 (2018). https://doi.org/10.1016/j.jspd.2018.09.036
Published:
Issue Date:
DOI: https://doi.org/10.1016/j.jspd.2018.09.036